NL-OMON50225招募中不适用
on Invasive Cancer Test (NICT) : a pilot study - NICT
Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Patients with newly diagnosed breast cancer, colorectal cancer, non-small cell
- •lung cancer or glioblastoma, Patients age > 18 years, willing and able to
- •comply with the protocol as judged by the investigator with a signed informed
排除标准
- •Patients with a history of malignant disease other than the disease under
- •study, with an exception for adequately treated squamous cell carcinoma of the
- •skin, basal cell carcinoma of the skin and in situ cervix carcinoma.
研究者
相似试验
招募中
不适用
A pilot study investigating the possibility to detect cancer DNA in the blood of cancer patientsBreast CancerColorectal CancerGliomaNon-small Cell Lung CancerNL-OMON22021Maastricht University Medical Center (MUMC)50
招募中
不适用
Non Invasive Cancer Test (NICT): a Proof of Principle Study.NeoplasmataNCT03019471Maastricht University Medical Center40
进行中（未招募）
不适用
A phase II Clinical Trial to Evaluate Intratumoral Injection of a Depot Formulation of Paclitaxel (DTS-301) as Neoadjuvant Therapy of Patients with Breast CancerInvasive primary breast cancerEUCTR2005-001417-18-HUDIATOS S.A.10
暂停
不适用
A Biomarker Study Using Tumor-infiltrating Regulatory T Cells to Predict the Efficacy to Immune Checkpoint Inhibitors in Patients with Non-Small Cell Lung Cancer and Malignant Melanomaon-Small Cell Lung Cancer or Malignant MelanomaJPRN-UMIN000044535Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Department of Hematology, Oncology and Respiratory Medicine130
进行中（未招募）
不适用
A Phase II Clinical Trial to Evaluate Intratumoral Injection of a Depot Formulation of Paclitaxel (DTS-301) as Neoadjuvant Therapy of Patients with Breast CancerInvasive primary breast cancerEUCTR2005-001417-18-ATDIATOS S.A.10